Legal Representation
Attorney
Steven A. Abreu
USPTO Deadlines
Next Deadline
140 days remaining
NOA E-Mailed - SOU Required
Due Date
December 03, 2025
Extension Available
Until June 03, 2026
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 14, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 14, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 14, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Mar 14, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 14, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Feb 3, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Feb 3, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Feb 3, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jan 6, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 26, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 4, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 4, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 4, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 20, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 22, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 7, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing temporary use of online non-downloadable software for data conversion, acquisition, reporting, presentation, integration, visualization and analysis in the field of pharmaceutical and biotherapeutic research, development and manufacturing; Providing temporary use of online non-downloadable software for integration of research, development, and manufacturing processes and analytical instrumentation, equipment and data in the field of pharmaceutical and biotherapeutic research, development and manufacturing; Providing temporary use of online non-downloadable software for data conversion, acquisition, reporting, presentation, integration, visualization and analysis; Providing temporary use of online non-downloadable software for data conversion, acquisition, reporting, presentation, integration, visualization and analysis for use with scientific instruments; Software as a service (SAAS) services featuring software for data conversion, acquisition, reporting, presentation, integration, visualization and analysis in the field of pharmaceutical and biotherapeutic research, development and manufacturing; Software as a service (SAAS) services featuring software for integration of research, development, and manufacturing processes and analytical instrumentation, equipment and data in the field of pharmaceutical and biotherapeutic research, development and manufacturing; Software as a service (SAAS) services featuring software for data conversion, acquisition, reporting, presentation, integration, visualization and analysis; Software as a service (SAAS) services featuring software for data conversion, acquisition, reporting, presentation, integration, visualization and analysis for use with scientific instruments
Additional Information
Pseudo Mark
Q PIX INSIGHTS
Classification
International Classes
042